BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2479272)

  • 1. Immunologic characterization of Ewing's sarcoma using mesenchymal and neural markers.
    Lizard-Nacol S; Lizard G; Justrabo E; Turc-Carel C
    Am J Pathol; 1989 Nov; 135(5):847-55. PubMed ID: 2479272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunocytologic study of light cell lines established in vitro from Ewing's sarcoma. Identification of neural markers].
    Lizard-Nacol S; Justrabo E; Mugneret F; Volk C; Turc-Carel C
    C R Seances Soc Biol Fil; 1988; 182(1):118-25. PubMed ID: 2972341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological characterization of a Ewing's sarcoma case.
    Lizard-Nacol S; Mugneret F; Turc-Carel C; Justrabo E
    Cancer Detect Prev; 1988; 12(1-6):297-302. PubMed ID: 3180134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroectoderm-associated antigens on Ewing's sarcoma cell lines.
    Lipinski M; Braham K; Philip I; Wiels J; Philip T; Goridis C; Lenoir GM; Tursz T
    Cancer Res; 1987 Jan; 47(1):183-7. PubMed ID: 3024814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunocytochemical and biochemical studies of an Ewing sarcoma cell line: evidence for neural differentiation in vitro].
    van Valen F; Prior R; Wechsler W; Jürgens H; Schäfer U; Keck E
    Klin Padiatr; 1988; 200(3):267-70. PubMed ID: 2850402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies.
    Lipinski M; Braham K; Philip I; Wiels J; Philip T; Dellagi K; Goridis C; Lenoir GM; Tursz T
    J Cell Biochem; 1986; 31(4):289-96. PubMed ID: 3760036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primitive neuroectodermal tumors of bone and soft tissue. With reference to histologic differentiation in primary or metastatic foci.
    Ushigome S; Shimoda T; Nikaido T; Nakamori K; Miyazawa Y; Shishikura A; Takakuwa T; Ubayama Y; Spjut HJ
    Acta Pathol Jpn; 1992 Jul; 42(7):483-93. PubMed ID: 1414358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen.
    Hamilton G; Fellinger EJ; Schratter I; Fritsch A
    Cancer Res; 1988 Nov; 48(21):6127-31. PubMed ID: 2844401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ewing's sarcoma. Characterization in established cultures and evidence of its histogenesis.
    Dickman PS; Liotta LA; Triche TJ
    Lab Invest; 1982 Oct; 47(4):375-82. PubMed ID: 6750238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Round cell tumours of bone.
    Roessner A; Jürgens H
    Pathol Res Pract; 1993 Dec; 189(10):111-36. PubMed ID: 8183732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histogenesis of Ewing's sarcoma. An evaluation of intermediate filaments and endothelial cell markers.
    Miettinen M; Lehto VP; Virtanen I
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(3):277-84. PubMed ID: 6135272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
    Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
    Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
    Navarro S; Giraudo P; Karseladze AI; Smirnov A; Petrovichev N; Savelov N; Alvarado-Cabrero I; Llombart-Bosch A
    Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of a new Ewing's sarcoma cell line from a malignant pleural effusion.
    Schiavo R; Tullio C; La Grotteria M; Andreotti IC; Scarpati B; Romiti L; Bozzi F; Pedrazzoli P; Siena S
    Anticancer Res; 2007; 27(5A):3273-8. PubMed ID: 17970070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
    Kontny HU; Hämmerle K; Klein R; Shayan P; Mackall CL; Niemeyer CM
    Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological study of Ewing's sarcoma/primitive neuroectodermal tumor in oral and maxillofacial region].
    He HW; Liu LK; Li YN; Wang D; He ZX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Sep; 40(5):379-82. PubMed ID: 16255919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroectodermal differentiation in "extraskeletal Ewing's sarcoma".
    Kudo M
    Acta Pathol Jpn; 1989 Dec; 39(12):795-802. PubMed ID: 2560312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma. An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms.
    Navarro S; Cavazzana AO; Llombart-Bosch A; Triche TJ
    Arch Pathol Lab Med; 1994 Jun; 118(6):608-15. PubMed ID: 8204006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
    Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
    J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.